Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial

Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page was updated to Revision v3.0.2, replacing the previous v3.0.1 tag; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T21:39:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T18:04:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and resources related to Mucopolysaccharidosis IV, while removing some previous location and disease-related terms.
    Difference
    2%
    Check dated 2025-08-31T12:22:22.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:41:18.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:33:16.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-01T18:54:49.000Z thumbnail image

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.